INVESTING IN THE
NEXT STANDARD OF SURGICAL SAFETY
>3.2M
Surgeries
Globally
per Year
600K+
Hysterectomies
Annually in
the U.S.
~70% of
Women Develop Uterine Fibroids
by Age 50
$1B by 2030
Laparoscopic
Retrieval Bag Market Size
WHY INVEST IN ARK SURGICAL
“What attracted me to Ark was not simply the technology. It was the combination of a clear clinical need, a differentiated solution, regulatory clearance and a realistic path to commercial scale.”
Joseph LaBruzzo
Investor, Board Member,
President & CEO, U.S. Operations
SERIES A
Ark Surgical is continuing its Series A financing round to support the next phase of U.S. commercial expansion, strengthen sales and clinical support, scale manufacturing and advance the company’s broader product pipeline.
The current Series A round has already attracted investment from physicians and experienced medical device executives, bringing both capital and deep industry expertise to Ark’s next phase of growth.
POSITIONED FOR GROWTH
+ FDA-cleared
+ Clear clinical need
+ Differentiated dual-wall design
+ Growing U.S. adoption
+ JNF & IIA backing
+ Physician & industry investment
+ Expanding U.S. infrastructure
+ Broader product pipeline
Ark Surgical is entering a pivotal stage of growth.
THE NEXT STANDARD OF SURGICAL CARE
Your investment will help build the next standard of surgical care by accelerating U.S. hospital adoption, scaling commercial and manufacturing capabilities, and advancing Ark Surgical’s next generation of surgical safety solutions.
Contact our team here to request additional company and investment information.
LATEST NEWS
